Second, we reviewed the literature dealing with ocular side effects of the listed chemotherapy agents in Table 4. However, several rarely expressed symptoms/side effects (e.g., abdominal pain, frequent day time urination) received high bothersomeness ratings. For more information, ask your doctor or pharmacist.Call your doctor for medical advice about side effects.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online ( [WEB] ) or by phone (1-800-332-1088). Call your doctor at once if you have fast or pounding heartbeats, swelling in your lower legs, a cough , fever , shortness of breath, vision changes, eye pain, increased sensitivity to light, or if you feel light-headed. Osimertinib can cause serious side effects on your heart, lungs, or vision. If experienced, these tend to have a Severe expression. If experienced, these tend to have a Severe expressionIf experienced, these tend to have a Less Severe expressionIf experienced, these tend to have a Severe expressionIf experienced, these tend to have a Less Severe expressionIf experienced, these tend to have a Severe expressionIf experienced, these tend to have a Less Severe expressionSelected from data included with permission and copyrighted by First Databank, Inc. Tell your doctor if you have any side effect that bothers you or that does not go away. TAGRISSO is a registered trademark and AstraZeneca Access 360 is a trademark of the AstraZeneca group of companies.
Although quite a few agents listed above had a variety of ocular side effects, none of them had any evidence specifically dealing with corneal epithelial changes (Table 5). These are some of the most common or important side effects: Diarrhea. Talk to your care team about these recommendations. Osimertinib is administered in the form of a tablet (oral). Call your doctor if you have any unusual problems while taking this medication. You may report side effects to FDA at Your doctor will perform a test to make sure that TAGRISSO is right for you.It is not known if TAGRISSO is safe and effective in children. The typical osimertinib dose is an 80 mg tablet once a day until the condition progresses or unacceptable toxicity or side effects become present.
This product is available in the following dosage forms: Tablet; Before Using These are not all the possible side effects of TAGRISSO. For more information, ask your doctor or pharmacist.Call your doctor for medical advice about side effects. Contact Us If you would like additional information regarding AstraZeneca products, please contact the Information Center at AstraZeneca in the US at 1-800-236-9933, 1-8 - 0 - 0- 2 36-9933, Monday through Friday, 8 AM to 6 PM ET, excluding holidays. This medicine is available only with your doctor's prescription. You may report side effects related to AstraZeneca products by clicking here. The effects on female fertility showed a trend toward reversibility; it is not known whether the effects on male fertility are reversible. What is TAGRISSO? TAGRISSO is used:Your doctor will perform a test to make sure that TAGRISSO is right for you.It is not known if TAGRISSO is safe and effective in children.Tell your doctor about all the medicines you take, including prescription and Tell your doctor if you have any side effect that bothers you or that does not go away.These are not all the possible side effects of TAGRISSO.
In male rats, degenerative changes were present in the testes of rats and dogs exposed to osimertinib for 1 month or more, with evidence of reversibility in the rat. If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) … Osimertinib may cause other side effects. You may report side effects to FDA at Tell your doctor about all the medicines you take, including prescription and Tell your doctor if you have any side effect that bothers you or that does not go away.These are not all the possible side effects of TAGRISSO. At the second interview, patients were highly satisfied with osimertinib and had a low level of difficulty in coping with side effects during treatment.